Sabra Health Care REIT, Inc. (SBRA) on Thursday updated its 2013 guidance to take into account the issuance of $200 million of 2023 Notes, redemption of $113.8 million of the 2018 Notes and investments through March 31, 2013 of $17.5 million.
In addition, the updated 2013 guidance no longer contemplates an issuance of $75.0 to $100.0 million of equity securities in 2013.
For fiscal 2013, the company now expects FFO to range between $1.53 and $1.57 per share and Normalized FFO, after adjusting for the redemption premium, write-off of deferred financing costs and issuance premiums associated with the redemption of $113.8 million of the 2018 Notes, to range between $1.79 and $1.83 per common share.
The company expects AFFO for fiscal 2013 to range between $1.42 and $1.46 per share and Normalized AFFO, after adjusting for the redemption premium, to range between $1.66 and $1.70 per share.
The company also said it now expects net income attributable to common stockholders for fiscal 2013 to range between $0.65 and $0.69 per share.
Analysts polled by Thomson Reuters currently expect the company to report FFO of $1.88 per share for the full year 2013. Analysts' estimates typically exclude special items.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.